speb/financial-data huggingface dataset:
SHILCTECH.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.25
SHILCTECH.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.24
SHILCTECH.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 2302000.00
SHILCTECH.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 2302000.00
SHILCTECH.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -628430000.00
SHILCTECH.NS balance_sheet (annual, 2026-03-31) — Total Assets: 5905141000.00
SHILCTECH.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 5905141000.00
SHILCTECH.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 4908460000.00
SHILCTECH.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 4908460000.00
SHILCTECH.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 4908460000.00
SHILCTECH.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 4908460000.00
SHILCTECH.NS income_statement (annual, 2026-03-31) — Total Expenses: 4618643000.00
SHILCTECH.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 1207428000.00
SHILCTECH.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 996681000.00
SHILCTECH.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 996681000.00
SHILCTECH.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 878946000.00
SHILCTECH.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 878946000.00
SHILCTECH.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 49104000.00
SHILCTECH.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 49104000.00
SHILCTECH.NS income_statement (annual, 2026-03-31) — Total Other Finance Cost: 4723000.00
SHILCTECH.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 0.00
SHILCTECH.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 0.00
SHILCTECH.NS income_statement (annual, 2026-03-31) — Total Unusual Items: -965000.00
SHILCTECH.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: -965000.00
SHILCTECH.NS balance_sheet (annual, 2026-03-31) — Work In Process: 103260000.00
SHILCTECH.NS balance_sheet (quarterly, 2026-03-31) — Work In Process: 103260000.00
SHILCTECH.NS balance_sheet (annual, 2026-03-31) — Working Capital: 4078623000.00
SHILCTECH.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 4078623000.00
SHILCTECH.NS income_statement (annual, 2026-03-31) — Write Off: 1849000.00
SHILPAMED.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -3556328000.00
SHILPAMED.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 7249514000.00
SHILPAMED.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -39337000.00
SHILPAMED.NS balance_sheet (annual, 2022-03-31) — Assets Held For Sale Current: 0.00
SHILPAMED.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 2962820000.00
SHILPAMED.NS cash_flow (annual, 2022-03-31) — Cash Dividends Paid: -89680000.00
SHILPAMED.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 34489000.00
SHILPAMED.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 303801000.00
SHILPAMED.NS cash_flow (annual, 2022-03-31) — Common Stock Dividend Paid: -89680000.00
SHILPAMED.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 2834000.00
SHILPAMED.NS cash_flow (annual, 2022-03-31) — Dividends Received Cfi: 10002000.00
SHILPAMED.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 753823000.00
SHILPAMED.NS cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of Business: -87911000.00
SHILPAMED.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 552269000.00
SHILPAMED.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 3902595000.00
SHILPAMED.NS balance_sheet (annual, 2022-03-31) — Held To Maturity Securities: 20000.00
SHILPAMED.NS income_statement (annual, 2022-03-31) — Interest Income: 20666000.00
SHILPAMED.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 20666000.00
SHILPAMED.NS balance_sheet (annual, 2022-03-31) — Investmentsin Associatesat Cost: 7734000.00
SHILPAMED.NS balance_sheet (annual, 2022-03-31) — Investmentsin Joint Venturesat Cost: 319476000.00
SHILPAMED.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 287273000.00
SHILPAMED.NS balance_sheet (annual, 2022-03-31) — Long Term Equity Investment: 319476000.00
SHILPAMED.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 8073626000.00
SHILPAMED.NS cash_flow (annual, 2022-03-31) — Net Investment Purchase And Sale: -173464000.00
SHILPAMED.NS cash_flow (annual, 2022-03-31) — Net Other Financing Charges: -1000.00
SHILPAMED.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Revenue: 192660000.00
SHILPAMED.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Liabilities: 547375000.00
SHILPAMED.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 70327000.00
SHILPAMED.NS cash_flow (annual, 2022-03-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
SHILPAMED.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 293024000.00
SHILPAMED.NS balance_sheet (annual, 2022-03-31) — Other Payable: 505912000.00
SHILPAMED.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 28597000.00
SHILPAMED.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 312020000.00
SHILPAMED.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 344914000.00
SHILPAMED.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
SHILPAMED.NS cash_flow (annual, 2022-03-31) — Purchase Of Business: 0.00
SHILPAMED.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 2056143000.00
SHILPAMED.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 11594000.00
SHILPAMED.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 11594000.00
SHILPAMED.NS income_statement (annual, 2022-03-31) — Research And Development: 550605000.00
SHILPAMED.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 2834000.00
SHILPAMED.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 10432049000.00
SHILPAMED.NS cash_flow (annual, 2022-03-31) — Sale Of PPE: 6111000.00
SHILPAMED.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 56589000.00
SHILPAMED.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 608858000.00
SHILPAMED.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 553000.00
SHILPAMED.NS balance_sheet (annual, 2022-03-31) — Total Tax Payable: 125547000.00
SHILPAMED.NS balance_sheet (annual, 2022-03-31) — Tradeand Other Payables Non Current: 50000000.00
SHILPAMED.NS balance_sheet (annual, 2022-03-31) — Work In Process: 449394000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — +Operating Expense: 6311992000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — +Total Revenue: 10434464000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 1428001000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 3243491000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -4376406000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 7249515000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -3254000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 136263000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 134219000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 173603796.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Basic EPS: -1.88
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 256223000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 3015324000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -2266674000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 21670000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 86802000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 213182000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 221919000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -95482000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 14899000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 198283000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Change In Inventory: 354173000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: 68117000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: -21993000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Change In Payable: -23228000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Change In Receivables: 650636000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: 1027705000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Changes In Cash: -68906000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Common Stock: 86802000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 17832770000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Common Stock Issuance: 0.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 4083038000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 4168439000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Current Assets: 7695546000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 3656000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Current Debt: 5069029000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 5072685000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 7844477000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 209245000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Depreciation: 818727000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 954990000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 954990000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 954990000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 173603796.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Diluted EPS: -1.88
SHILPAMED.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: -325332000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 2464000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Dividends Received Cfi: 5000000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — EBIT: 179753000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — EBITDA: 1134743000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: 3397000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — End Cash Position: 190714000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: 457980000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 652435000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: -467438000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: 2648000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of Business: 0.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 295291000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Goodwill: 455267000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 4861745000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 3243491000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 20253936000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Gross Profit: 6266025000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Held To Maturity Securities: 20000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Interest Expense: 562547000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 562547000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Interest Income: 17607000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 17607000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -579191000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 12762000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Inventory: 3198210000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 25789988000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -2326122000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 134219000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Investments In Other Ventures Under Equity Method: 29131000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Investmentsin Associatesat Cost: 0.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Investmentsin Joint Venturesat Cost: 372231000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 0.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 613176000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 18014000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 2888189000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 2906203000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 401362000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 176490000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 8327486000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Minority Interest: -89205000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Minority Interests: -15604000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: -89297000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 0.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Net Debt: 7744036000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: -40639000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Net Income: -325332000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: -325332000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: -309728000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: -325332000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: -325332000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: -382795000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: -309728000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Net Interest Income: -568914000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -89297000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 1138094000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -274529000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -568914000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Net Other Financing Charges: 1000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: 12087000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Net PPE: 15877530000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -2266674000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 1412623000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 12971025000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 174765000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 0.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 140508000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 176490000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 68347000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 1145418000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Normalized Income: -316694596.07
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 1799236000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Operating Income: -45967000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Operating Revenue: 10434464000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 86801898.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 3199000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: -3000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 876000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 4406478000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Other Inventories: 210061000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 560725000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 515000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 3256000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 140739000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 1608467000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Other Payable: 551484000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Other Properties: 4214912000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 65022000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 8737000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Other Special Charges: 2648000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Payables: 2127639000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 291495000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 871524000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Pretax Income: -382794000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 60297000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Purchase Of Business: -89297000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -2266674000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 1814745000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 4168439000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 954990000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 10095000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 10095000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Research And Development: 491023000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 3864000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 10011804000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Sale Of Business: 0.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 12087000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 26225000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 321516000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Share Issued: 86801898.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Special Income Charges: -10675000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 17832770000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 12971025000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: -2037596.07
SHILPAMED.NS income_statement (annual, 2023-03-31) — Tax Provision: -73066000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.19
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 88317000.00
SHILPAMED.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -323748000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Total Assets: 29039264000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 20720959000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Total Debt: 7978888000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 17743565000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Total Expenses: 10480431000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 11295699000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 21343718000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 3451222000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 23974000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 145690000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Total Unusual Items: -10675000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -10675000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Tradeand Other Payables Non Current: 50000000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Work In Process: 520969000.00
SHILPAMED.NS balance_sheet (annual, 2023-03-31) — Working Capital: -148931000.00
SHILPAMED.NS income_statement (annual, 2023-03-31) — Write Off: 8027000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — +Operating Expense: 6089406000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — +Total Revenue: 11516030000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 1741516000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 3920455000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -5068664000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 7249515000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -14648000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 289375000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 173603796.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Basic EPS: 1.84
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 190714000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 3277778000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -1845605000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 18014000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 86802000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 302256000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 302256000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 72797000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 229459000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -407729000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -90487000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: -58540000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Change In Payable: 336547000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -758987000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -979196000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 168596000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Common Stock: 86802000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 18010795000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 0.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 4453054000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 4080359000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Current Assets: 8762426000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 5293000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Current Debt: 3754274000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 3759567000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 6935886000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 216163000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Depreciation: 1078699000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 1078699000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 1078699000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 1078699000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 173603796.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Diluted EPS: 1.84
SHILPAMED.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 318743000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 2099000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Dividends Received Cfi: 0.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — EBIT: 1380543000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — EBITDA: 2459242000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: -41750000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — End Cash Position: 317560000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: 467749000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 824549000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: -478915000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -66612000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: -5436000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 216699000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Goodwill: 462308000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 5074482000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 3935103000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 21453648000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Gross Profit: 7428009000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Hedging Assets Current: 0.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Held To Maturity Securities: 20000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Impairment Of Capital Assets: 0.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Interest Expense: 837136000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 837136000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Interest Income: 13807000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 13807000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -923690000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 13840000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Inventory: 3449281000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 27442814000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -1665844000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 289375000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Investments In Other Ventures Under Equity Method: 53569000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Investmentsin Associatesat Cost: 260287000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Investmentsin Joint Venturesat Cost: 60016000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 0.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 616984000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 12721000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 5601599000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 5614320000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 113585000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 224292000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 8928753000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Minority Interest: -87372000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Minority Interests: -809000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: 44936000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 0.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Net Debt: 9053617000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: 8530000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Net Income: 318743000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 318743000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 319552000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 318743000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 318743000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 543407000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 319552000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Net Interest Income: -904230000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -65064000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 1396718000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 1233007000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -904230000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Net Other Financing Charges: -1000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: 120985000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Net PPE: 16384984000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -1724620000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: 163711000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 12936313000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Revenue: 158359000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 102614000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 0.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 224292000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 79057000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 2439708000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Normalized Income: 305069200.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 1366690000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Operating Income: 1338603000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Operating Revenue: 11508368000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 86801898.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Other Cash Adjustment Outside Changein Cash: -10000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: -9806000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 1428000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 876000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 4612174000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Other Inventories: 218624000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 867866000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 79397000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: 1000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 52862000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 1467442000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Other Payable: 660514000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Other Properties: 4177079000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 18984000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 30605000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Other Special Charges: -66743000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Payables: 2567002000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 298093000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 302310000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Pretax Income: 543407000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 79672000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Purchase Of Business: -65064000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -1845605000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 1710657000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 4080359000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 1078699000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 12536000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 12536000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Research And Development: 309692000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 15406000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 10337956000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Sale Of Business: 110000000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 120985000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 75400000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 292099000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Share Issued: 86801898.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Special Income Charges: 19534000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 18010795000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 12936313000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 18392100.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Tax Provision: 223855000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.30
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 763540000.00
SHILPAMED.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -411890000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Total Assets: 30932427000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 23612394000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Total Debt: 9373887000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 17923423000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Total Expenses: 10169765000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 12932858000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 22170001000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 5996972000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 80901000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 162873000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 61307000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 19534000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Work In Process: 695451000.00
SHILPAMED.NS balance_sheet (annual, 2024-03-31) — Working Capital: 1826540000.00
SHILPAMED.NS income_statement (annual, 2024-03-31) — Write Off: 47209000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 971042000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 3598295000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 425004000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 15448000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 97791000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 170051000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 365194000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 97791000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 23278798000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 4552868000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 8590437000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 1136000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 2249577000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 2250713000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 4944846000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 292594000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Goodwill: 462308000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 5247074000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 16233723000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 3265545000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 28169262000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 425004000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 14312000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 2640887000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 2655199000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 229326000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Minority Interest: -86949000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 4720413000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 16233723000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 18031724000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 23888000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 0.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 97790908.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 1266186000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 376827000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 23181007000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 4784766000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 653160000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 152066000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 11680855000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 195143000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Payables: 971042000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 97790908.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 23278798000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 18031724000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Taxes Receivable: 95217000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 31173286000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 25919685000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 4905912000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 23191849000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 7981437000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 22582849000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 3036591000.00
SHILPAMED.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 3645591000.00
SHILPAMED.NS income_statement (annual, 2025-03-31) — +Operating Expense: 6322000000.00
SHILPAMED.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 1616100000.00
SHILPAMED.NS income_statement (annual, 2025-03-31) — +Total Revenue: 12864300000.00
SHILPAMED.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 3308200000.00
SHILPAMED.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 953815000.00
SHILPAMED.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 953815000.00
SHILPAMED.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 4408356000.00
SHILPAMED.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 4408356000.00
SHILPAMED.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -5850147000.00
SHILPAMED.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -5850147000.00
SHILPAMED.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 12129589000.00
SHILPAMED.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 12129589000.00
SHILPAMED.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -26137000.00
SHILPAMED.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -26137000.00
SHILPAMED.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 407914000.00
SHILPAMED.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 407914000.00
SHILPAMED.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 194751244.00
SHILPAMED.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 196081081.00
SHILPAMED.NS income_statement (annual, 2025-03-31) — Basic EPS: 4.02
SHILPAMED.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 0.74
SHILPAMED.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 317600000.00
SHILPAMED.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 3393576000.00
SHILPAMED.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 3393576000.00
SHILPAMED.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -2436800000.00
SHILPAMED.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 13842000.00
SHILPAMED.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 13842000.00
SHILPAMED.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 97791000.00
SHILPAMED.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 97762000.00
SHILPAMED.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 259683000.00
SHILPAMED.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 259683000.00
SHILPAMED.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 259683000.00
SHILPAMED.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 259683000.00
SHILPAMED.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 6658000.00
SHILPAMED.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 6658000.00
SHILPAMED.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 253025000.00
SHILPAMED.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 253025000.00
SHILPAMED.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -223200000.00
SHILPAMED.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -449500000.00
SHILPAMED.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 546300000.00
SHILPAMED.NS cash_flow (annual, 2025-03-31) — Change In Payable: -700000000.00
SHILPAMED.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -554500000.00
SHILPAMED.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -1380900000.00
SHILPAMED.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -42100000.00
SHILPAMED.NS balance_sheet (annual, 2025-03-31) — Common Stock: 97791000.00
SHILPAMED.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 97762000.00
SHILPAMED.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 23630719000.00
SHILPAMED.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 23630719000.00
SHILPAMED.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 4891000000.00
SHILPAMED.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 4930059000.00
SHILPAMED.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 4930059000.00
SHILPAMED.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 4103900000.00
SHILPAMED.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1044900000.00
SHILPAMED.NS balance_sheet (annual, 2025-03-31) — Current Assets: 9856725000.00
SHILPAMED.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 9856725000.00
SHILPAMED.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 1361000.00
SHILPAMED.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 1361000.00
SHILPAMED.NS balance_sheet (annual, 2025-03-31) — Current Debt: 3544057000.00
SHILPAMED.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 3544057000.00
SHILPAMED.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 3545418000.00
SHILPAMED.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 3545418000.00
SHILPAMED.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 6742322000.00